United States Pharmaceuticals

Ocular Therapeutix, Inc. (OCUL)

Track

Track

Ocular Therapeutix experienced ten insider trading transactions over the past ninety days, all involving sales. Executives, including the Chief Operating Officer and Chief Scientific Officer, divested shares totaling approximately $666,205. These disposals occurred following the August 3rd earnings report, where the firm beat expectations by 12.5 percent, amid relatively stable stock performance.
Ticker: OCUL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ocular Therapeutix, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Planned sale
Price
468.29
Quantity 79,577 +31.8%
Value US$1,146,510
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
195.95
Quantity 59,993
Value US$1,666,437
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Planned sale
Price
179.72
Quantity 61,567 +30.9%
Value US$4,674,138
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
10.77
Quantity 21,649 -0.8%
Value US$233,160
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
10.78
Quantity 1,897 -0.6%
Value US$20,450
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.78
Quantity 3,296 -1.0%
Value US$35,531
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
10.78
Quantity 1,897
Value US$20,453
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
10.77
Quantity 21,649
Value US$233,186
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
10.78
Quantity 3,296
Value US$35,532
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
10.77
Quantity 3,035
Value US$32,702
1.6
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
8.27
Quantity 14,828 -4.7%
Value US$122,628
1.6
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
8.27
Quantity 14,828 -4.7%
Value US$122,628
1.6
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
8.27
Quantity 14,828
Value US$122,648
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
8.20
Quantity 21,156 -0.8%
Value US$173,479
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
8.20
Quantity 3,018 -0.9%
Value US$24,748
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
8.20
Quantity 2,967 -1.1%
Value US$24,329
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
8.20
Quantity 1,858 -0.6%
Value US$15,236
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 1,858
Value US$15,237
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 2,967
Value US$24,334
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 3,018
Value US$24,745
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
8.20
Quantity 21,156
Value US$173,513
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
8.28
Quantity 20,056 -0.7%
Value US$166,064
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
8.28
Quantity 2,810 -1.0%
Value US$23,267
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
8.28
Quantity 3,057 -0.9%
Value US$25,312
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
8.28
Quantity 1,759 -0.5%
Value US$14,565
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 2,810
Value US$23,268
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 20,056
Value US$166,086
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 3,057
Value US$25,298
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 1,759
Value US$14,563
1.6
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
7.74
Quantity 3,510 -1.1%
Value US$27,167
3.4
LINDSTROM RICHARD L MD Non-Executive Director
Transaction date
Purchase
Price
7.66
Quantity 60,229 +32.3%
Value US$461,354
1.6
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
7.74
Quantity 3,510
Value US$27,170
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
9.04
Quantity 11,446 -3.0%
Value US$103,472
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
9.04
Quantity 10,348 -3.0%
Value US$93,546
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
9.04
Quantity 124,882 -4.0%
Value US$1,128,933
1.6
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
9.04
Quantity 7,863 -2.4%
Value US$71,082
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 11,446
Value US$103,481
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 124,882
Value US$1,128,584
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 6,864
Value US$62,034
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 10,348
Value US$93,560
1.6
NADIA K. WAHEED Officer Officer
Transaction date
Proposed sale
Price
9.04
Quantity 7,863
Value US$71,082
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
8.54
Quantity 6,035 -1.6%
Value US$51,539
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
8.54
Quantity 6,035 -1.6%
Value US$51,539
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
8.54
Quantity 4,408
Value US$37,636
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
8.54
Quantity 6,035
Value US$51,541
2.2
Notman Donald Chief Operating Officer Officer
Transaction date
Sale
Price
9.14
Quantity 5,455 -1.4%
Value US$49,859
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
9.14
Quantity 5,455
Value US$49,873
STEVE MEYERS Officer Officer
Transaction date
Proposed sale
Price
9.14
Quantity 3,052
Value US$27,904
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
12.02
Quantity 3,007 -1.5%
Value US$36,144
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
12.04
Quantity 3,469 -1.4%
Value US$41,767
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
12.04
Quantity 1,878 -0.7%
Value US$22,611
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
12.04
Quantity 19,530 -0.6%
Value US$235,141
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 19,530
Value US$235,083
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 1,878
Value US$22,616
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
12.02
Quantity 3,007
Value US$36,150
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 3,469
Value US$41,772
2.1
Saroj Namrata Chief Business Officer Officer
Transaction date
Sale
Price
10.74
Quantity 25,865 -12.9%
Value US$277,790
2.1
NAMRATA SAROJ Officer Officer
Transaction date
Proposed sale
Price
10.74
Quantity 25,865
Value US$277,909
3.1
Anderman Todd Chief Legal Officer Officer
Transaction date
Sale
Price
12.34
Quantity 11,132 -11.3%
Value US$137,369
3.1
TODD ANDERMAN Officer Officer
Transaction date
Proposed sale
Price
12.34
Quantity 11,132
Value US$137,400
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
11.04
Quantity 10,502 -4.0%
Value US$115,942
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
11.03
Quantity 9,653 -4.7%
Value US$106,473
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
11.04
Quantity 10,502
Value US$115,890
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
11.03
Quantity 9,653
Value US$106,516
2.2
Notman Donald See Remarks Officer
Transaction date
Planned sale
Price
12.43
Quantity 1,066 -0.3%
Value US$13,250
2.2
DONALD D NOTMAN JR. Officer Officer
Transaction date
Proposed sale
Price
12.43
Quantity 1,066
Value US$13,245
3.7
Heier Jeffrey S. Chief Scientific Officer Officer
Transaction date
Sale
Price
12.04
Quantity 3,063 -1.2%
Value US$36,879
2.7
Kaiser Peter Chief Development Officer Officer
Transaction date
Sale
Price
12.04
Quantity 3,011 -1.5%
Value US$36,252
2.9
Dugel Pravin See Remarks Executive Director
Transaction date
Sale
Price
12.04
Quantity 21,494 -0.7%
Value US$258,788
2.8
Nayak Sanjay Chief Strategy Officer Officer
Transaction date
Sale
Price
12.04
Quantity 1,885 -0.7%
Value US$22,695
2.9
PRAVIN DUGEL Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 21,494
Value US$258,758
2.8
SANJAY NAYAK Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 1,885
Value US$22,702
3.7
JEFFREY S. HEIER Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 3,063
Value US$36,883
2.7
PETER KAZUO KAISER Officer Officer
Transaction date
Proposed sale
Price
12.04
Quantity 3,011
Value US$36,253
1.6
Waheed Nadia Chief Medical Officer Officer
Transaction date
Sale
Price
8.05
Quantity 13,861 -6.3%
Value US$111,581
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-08-31 PlS Planned sale
2.2
Notman Donald

Chief Operating Officer

Officer
79,577 +31.8%
468.29
US$1,146,510 		79,577 +31.8% 468.29 US$1,146,510
2026-08-31 2026-08-31 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
59,993
195.95
US$1,666,437 		59,993 195.95 US$1,666,437
2026-08-26 2026-08-24 PlS Planned sale
2.7
Kaiser Peter

Chief Development Officer

Officer
61,567 +30.9%
179.72
US$4,674,138 		61,567 +30.9% 179.72 US$4,674,138
2026-08-26 2026-08-24 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
21,649 -0.8%
10.77
US$233,160 		21,649 -0.8% 10.77 US$233,160
2026-08-26 2026-08-24 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,897 -0.6%
10.78
US$20,450 		1,897 -0.6% 10.78 US$20,450
2026-08-26 2026-08-24 PlS Planned sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,296 -1.0%
10.78
US$35,531 		3,296 -1.0% 10.78 US$35,531
2026-08-24 2026-08-24 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,897
10.78
US$20,453 		1,897 10.78 US$20,453
2026-08-24 2026-08-24 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
21,649
10.77
US$233,186 		21,649 10.77 US$233,186
2026-08-24 2026-08-24 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,296
10.78
US$35,532 		3,296 10.78 US$35,532
2026-08-24 2026-08-24 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,035
10.77
US$32,702 		3,035 10.77 US$32,702
2026-06-05 2026-06-03 S Sale
1.6
Waheed Nadia

Chief Medical Officer

Officer
14,828 -4.7%
8.27
US$122,628 		14,828 -4.7% 8.27 US$122,628
2026-06-05 2026-06-03 S Sale
1.6
Waheed Nadia

Chief Medical Officer

Officer
14,828 -4.7%
8.27
US$122,628 		14,828 -4.7% 8.27 US$122,628
2026-06-03 2026-06-03 PrS Proposed sale
1.6
NADIA K. WAHEED

Officer

Officer
14,828
8.27
US$122,648 		14,828 8.27 US$122,648
2026-05-28 2026-05-26 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
21,156 -0.8%
8.20
US$173,479 		21,156 -0.8% 8.20 US$173,479
2026-05-28 2026-05-26 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,018 -0.9%
8.20
US$24,748 		3,018 -0.9% 8.20 US$24,748
2026-05-28 2026-05-26 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,967 -1.1%
8.20
US$24,329 		2,967 -1.1% 8.20 US$24,329
2026-05-28 2026-05-26 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,858 -0.6%
8.20
US$15,236 		1,858 -0.6% 8.20 US$15,236
2026-05-26 2026-05-26 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,858
8.20
US$15,237 		1,858 8.20 US$15,237
2026-05-26 2026-05-26 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,967
8.20
US$24,334 		2,967 8.20 US$24,334
2026-05-26 2026-05-26 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,018
8.20
US$24,745 		3,018 8.20 US$24,745
2026-05-26 2026-05-26 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
21,156
8.20
US$173,513 		21,156 8.20 US$173,513
2026-02-25 2026-02-23 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
20,056 -0.7%
8.28
US$166,064 		20,056 -0.7% 8.28 US$166,064
2026-02-25 2026-02-23 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
2,810 -1.0%
8.28
US$23,267 		2,810 -1.0% 8.28 US$23,267
2026-02-25 2026-02-23 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,057 -0.9%
8.28
US$25,312 		3,057 -0.9% 8.28 US$25,312
2026-02-25 2026-02-23 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,759 -0.5%
8.28
US$14,565 		1,759 -0.5% 8.28 US$14,565
2026-02-23 2026-02-23 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
2,810
8.28
US$23,268 		2,810 8.28 US$23,268
2026-02-23 2026-02-23 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
20,056
8.28
US$166,086 		20,056 8.28 US$166,086
2026-02-23 2026-02-23 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,057
8.28
US$25,298 		3,057 8.28 US$25,298
2026-02-23 2026-02-23 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,759
8.28
US$14,563 		1,759 8.28 US$14,563
2026-02-24 2026-02-20 S Sale
1.6
Waheed Nadia

Chief Medical Officer

Officer
3,510 -1.1%
7.74
US$27,167 		3,510 -1.1% 7.74 US$27,167
2026-02-24 2026-02-20 B Purchase
3.4
LINDSTROM RICHARD L MD
Non-Executive Director
60,229 +32.3%
7.66
US$461,354 		60,229 +32.3% 7.66 US$461,354
2026-02-20 2026-02-20 PrS Proposed sale
1.6
NADIA K. WAHEED

Officer

Officer
3,510
7.74
US$27,170 		3,510 7.74 US$27,170
2026-02-17 2026-02-12 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
11,446 -3.0%
9.04
US$103,472 		11,446 -3.0% 9.04 US$103,472
2026-02-17 2026-02-12 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
10,348 -3.0%
9.04
US$93,546 		10,348 -3.0% 9.04 US$93,546
2026-02-17 2026-02-12 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
124,882 -4.0%
9.04
US$1,128,933 		124,882 -4.0% 9.04 US$1,128,933
2026-02-17 2026-02-12 S Sale
1.6
Waheed Nadia

Chief Medical Officer

Officer
7,863 -2.4%
9.04
US$71,082 		7,863 -2.4% 9.04 US$71,082
2026-02-12 2026-02-12 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
11,446
9.04
US$103,481 		11,446 9.04 US$103,481
2026-02-12 2026-02-12 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
124,882
9.04
US$1,128,584 		124,882 9.04 US$1,128,584
2026-02-12 2026-02-12 PrS Proposed sale
STEVE MEYERS

Officer

Officer
6,864
9.04
US$62,034 		6,864 9.04 US$62,034
2026-02-12 2026-02-12 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
10,348
9.04
US$93,560 		10,348 9.04 US$93,560
2026-02-12 2026-02-12 PrS Proposed sale
1.6
NADIA K. WAHEED

Officer

Officer
7,863
9.04
US$71,082 		7,863 9.04 US$71,082
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
6,035 -1.6%
8.54
US$51,539 		6,035 -1.6% 8.54 US$51,539
2026-02-04 2026-02-04 PrS Proposed sale
STEVE MEYERS

Officer

Officer
4,408
8.54
US$37,636 		4,408 8.54 US$37,636
2026-02-04 2026-02-04 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
6,035
8.54
US$51,541 		6,035 8.54 US$51,541
2026-02-04 2026-02-02 S Sale
2.2
Notman Donald

Chief Operating Officer

Officer
5,455 -1.4%
9.14
US$49,859 		5,455 -1.4% 9.14 US$49,859
2026-02-02 2026-02-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
5,455
9.14
US$49,873 		5,455 9.14 US$49,873
2026-02-02 2026-02-02 PrS Proposed sale
STEVE MEYERS

Officer

Officer
3,052
9.14
US$27,904 		3,052 9.14 US$27,904
2025-11-26 2025-11-24 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,007 -1.5%
12.02
US$36,144 		3,007 -1.5% 12.02 US$36,144
2025-11-26 2025-11-24 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,469 -1.4%
12.04
US$41,767 		3,469 -1.4% 12.04 US$41,767
2025-11-26 2025-11-24 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,878 -0.7%
12.04
US$22,611 		1,878 -0.7% 12.04 US$22,611
2025-11-26 2025-11-24 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
19,530 -0.6%
12.04
US$235,141 		19,530 -0.6% 12.04 US$235,141
2025-11-24 2025-11-24 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
19,530
12.04
US$235,083 		19,530 12.04 US$235,083
2025-11-24 2025-11-24 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,878
12.04
US$22,616 		1,878 12.04 US$22,616
2025-11-24 2025-11-24 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,007
12.02
US$36,150 		3,007 12.02 US$36,150
2025-11-24 2025-11-24 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,469
12.04
US$41,772 		3,469 12.04 US$41,772
2025-11-07 2025-11-05 S Sale
2.1
Saroj Namrata

Chief Business Officer

Officer
25,865 -12.9%
10.74
US$277,790 		25,865 -12.9% 10.74 US$277,790
2025-11-05 2025-11-05 PrS Proposed sale
2.1
NAMRATA SAROJ

Officer

Officer
25,865
10.74
US$277,909 		25,865 10.74 US$277,909
2025-10-10 2025-10-08 S Sale
3.1
Anderman Todd

Chief Legal Officer

Officer
11,132 -11.3%
12.34
US$137,369 		11,132 -11.3% 12.34 US$137,369
2025-10-08 2025-10-08 PrS Proposed sale
3.1
TODD ANDERMAN

Officer

Officer
11,132
12.34
US$137,400 		11,132 12.34 US$137,400
2025-10-06 2025-10-02 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
10,502 -4.0%
11.04
US$115,942 		10,502 -4.0% 11.04 US$115,942
2025-10-06 2025-10-02 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
9,653 -4.7%
11.03
US$106,473 		9,653 -4.7% 11.03 US$106,473
2025-10-02 2025-10-02 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
10,502
11.04
US$115,890 		10,502 11.04 US$115,890
2025-10-02 2025-10-02 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
9,653
11.03
US$106,516 		9,653 11.03 US$106,516
2025-09-04 2025-09-02 PlS Planned sale
2.2
Notman Donald

See Remarks

Officer
1,066 -0.3%
12.43
US$13,250 		1,066 -0.3% 12.43 US$13,250
2025-09-02 2025-09-02 PrS Proposed sale
2.2
DONALD D NOTMAN JR.

Officer

Officer
1,066
12.43
US$13,245 		1,066 12.43 US$13,245
2025-08-27 2025-08-25 S Sale
3.7
Heier Jeffrey S.

Chief Scientific Officer

Officer
3,063 -1.2%
12.04
US$36,879 		3,063 -1.2% 12.04 US$36,879
2025-08-27 2025-08-25 S Sale
2.7
Kaiser Peter

Chief Development Officer

Officer
3,011 -1.5%
12.04
US$36,252 		3,011 -1.5% 12.04 US$36,252
2025-08-27 2025-08-25 S Sale
2.9
Dugel Pravin

See Remarks

Executive Director
21,494 -0.7%
12.04
US$258,788 		21,494 -0.7% 12.04 US$258,788
2025-08-27 2025-08-25 S Sale
2.8
Nayak Sanjay

Chief Strategy Officer

Officer
1,885 -0.7%
12.04
US$22,695 		1,885 -0.7% 12.04 US$22,695
2025-08-25 2025-08-25 PrS Proposed sale
2.9
PRAVIN DUGEL

Officer

Officer
21,494
12.04
US$258,758 		21,494 12.04 US$258,758
2025-08-25 2025-08-25 PrS Proposed sale
2.8
SANJAY NAYAK

Officer

Officer
1,885
12.04
US$22,702 		1,885 12.04 US$22,702
2025-08-25 2025-08-25 PrS Proposed sale
3.7
JEFFREY S. HEIER

Officer

Officer
3,063
12.04
US$36,883 		3,063 12.04 US$36,883
2025-08-25 2025-08-25 PrS Proposed sale
2.7
PETER KAZUO KAISER

Officer

Officer
3,011
12.04
US$36,253 		3,011 12.04 US$36,253
2025-06-03 2025-06-02 S Sale
1.6
Waheed Nadia

Chief Medical Officer

Officer
13,861 -6.3%
8.05
US$111,581 		13,861 -6.3% 8.05 US$111,581
Explore more

More insider trading research around Ocular Therapeutix, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America